Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
Clinical trial update on a precision-based immunotherapy program for primary liver cancer, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update for Becotatug Vedotin (MRG003) in previously treated advanced hepatocellular carcinoma; study is currently rec…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Clinical trial registry entry for real-world evaluation of HistoSonics' Edison System for treating liver tumors; study is currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body. [Phase 1, Phase 2]
Pfizer is testing PF-08634404 as a single-agent and combination therapy for unresectable or advanced hepatocellular carcinoma in a Phase 1/2…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating autologous dendritic cell therapy and Prevnar vaccine with immune checkpoint inhibition following high-dose exter…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing [Phase 1]
Phase 1 clinical trial investigating therapeutic drug monitoring-based dosing of atezolizumab across multiple cancers, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer [Phase 1, Phase 2]
A dose-defining study of tirapazamine combined with embolization in liver cancer (hepatocellular carcinoma) is in Phase 1/Phase 2 and curren…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: AI-Assisted Staging and Treatment Decision-Making for Hepatocellular Carcinoma
A clinical trial evaluating AI-assisted staging and treatment decision-making for hepatocellular carcinoma is currently recruiting at Beijin…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Phase 2 Study of WGI-0301 Plus Lenvatinib in Patients With Advanced HCC [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/Phase 2 study evaluating WGI-0301 in combination with Lenvatinib for advanced hepatocellular …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer [Phase 1]
This clinical trial update reports on a Phase 1 study evaluating a three-drug combination of IRX-2, cyclophosphamide, and nivolumab in patie…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
A completed clinical trial investigating new serum markers for diagnosing hepatocellular carcinoma (liver cancer).
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
This document describes a longitudinal observational study evaluating the natural history and management of patients with hepatocellular car…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Denosumab Strategy for Liver Cancer With Bone Metastases [Phase 2]
A Phase 2 clinical trial evaluating denosumab as a strategy for hepatocellular carcinoma with bone metastases. The study is currently not ye…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: The Effects of a Nurse-led TGA-based Pre-rehabilitation Planning on Perioperative Outcomes in Patients With Liver Cancer: Study and Protocol [NA]
A study protocol evaluating a nurse-led, TGA-based pre-rehabilitation planning approach to improve perioperative outcomes in patients with l…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases [NA]
Tongji Hospital is conducting a clinical trial on surgery plus systemic therapy for hepatocellular carcinoma with extrahepatic metastases; t…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer [Phase 2]
A Phase 2 study evaluating novel immunomodulators as both monotherapy and in combination with anticancer agents for advanced hepatobiliary c…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy [Phase 2]
A Phase 2 trial evaluating the combination of Benmelstobart, Anlotinib, and SBRT for hepatocellular carcinoma patients who failed first-line…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectable, TP53-Mutated Hepatocellular Carcinoma [NA]
A clinical trial protocol evaluating Firsekibart, Tislelizumab, and Lenvatinib in unresectable hepatocellular carcinoma with TP53 mutation; …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating targeting ischemia-induced autophagy dependence in hepatocellular carcinoma is currently recruiting…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Combination of TATE and PD-1 Inhibitor in Liver Cancer [Phase 2]
Phase 2 clinical trial updating on the combination of TATE and a PD-1 inhibitor for hepatocellular carcinoma and gastric cancer, currently r…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Patient Preference for Subcutaneous vs. Intravenous Immune Therapy [Phase 2]
Phase 2 clinical trial update on patient preference for subcutaneous versus intravenous immune therapy; the study is currently recruiting ac…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function [Phase 1]
Phase 1 study evaluating radiation therapy for patients with hepatocellular carcinoma, cholangiocarcinoma, or liver metastases who have impa…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
ClinicalTrials.gov update announcing an actively recruiting study of chronic liver diseases associated with alcohol use and metabolic syndro…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Scout Dose of Resin Microspheres [NA]
This trial update notes that a Scout dose study of resin microspheres is recruiting for liver-directed radioembolization in hepatocellular c…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepatocellular Carcinoma as First-line Treatment. [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating the combination of IBI310 and Sintilimab as first-line therapy for hepatocellular carcinoma and is …